| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 98 | 100 | 45 | 434 | | Cost of Revenue | 79 | 152 | 26 | 327 | | | Gross Profit | 18 | (52) | 19 | 107 | | | Operating Expenses | | Research Development | 3,076 | 2,964 | 3,002 | 3,240 | | Selling General and Administrative | 5,124 | 3,822 | 3,104 | 2,674 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,181) | (6,837) | (6,087) | (5,807) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 95 | 87 | 83 | 132 | | Earnings Before Interest And Taxes | (8,086) | (6,750) | (6,004) | (5,675) | | Interest Expense | 52 | 3,977 | 5,345 | 6,363 | | Income Before Tax | (8,139) | (10,728) | (11,349) | (12,038) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,139) | (10,728) | (11,349) | (12,038) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,139) | (10,728) | (11,349) | (12,038) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,139) | ($10,728) | ($11,349) | ($12,038) |
|
0.02% Nasdaq 
Income Statement
